Library Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 1,876 - 1,900 of 2,711 « 1 … 74 75 76 77 78 … 109 » Optimal Management of Limited Stage SCLC By: Paul Bunn, MD View PDF Targeting CEACAM5 and ROR1/ROR2 in NSCLC By: Paul Bunn, MD View PDF Optimal Management of Limited Stage SCLC By: Paul Bunn, MD View Video Targeting CEACAM5 and ROR1/ROR2 in NSCLC By: Paul Bunn, MD View Video Early-Stage / Locally Advanced Lung Cancer By: Paul Bunn, MD, FASCO View PDF Early-Stage / Locally Advanced Lung Cancer By: Paul Bunn, MD, FASCO View Video Lung Cancer Immunotherapy By: Pedro G. Solivan, MD View PDF EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors By: Pedro G. Solivan, MD View PDF Front Line Metastatic NSCLC By: Pedro G. Solivan, MD View PDF Lung Cancer Session By: Pedro G. Solivan, MD; Edgardo S. Santos Castillero, MD, FACP; Luis E. Raez, MD, FACP, FCCP; Genelis Domingo, MD View Video Other Targeted Agents in NSCLC By: Pedro Solivan, MD View PDF Addressing RET, MET, and EGFR/HER-2 Exon 20 insertion By: Pedro Solivan, MD View PDF MET, RAF and NTRK By: Pedro Solivan, MD View PDF Biomarkers in NSCLC Current Status and Future Directions By: Philip Mack, PhD View PDF Biomarkers in NSCLC: Current Status and Future Directions By: Philip Mack, PhD View Video Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy By: Primo Lara, Jr, MD View PDF Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy By: Primo Lara, Jr, MD View PDF Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy By: Primo Lara, Jr, MD View Video Squamous Cell Carcinoma By: Primo N. Lara, Jr., MD View PDF Stage III Non-Surgical NSCLC: Optimal Radiation Therapy Approach By: Puneeth Iyengar, MD View PDF Stage III Non-Surgical NSCLC: Optimal Radiation Therapy Approach By: Puneeth Iyengar, MD View Video Exploiting the Immunomodulatory Properties of Radiation Therapy By: Puneeth Iyengar, MD, PhD View PDF 2024 Metastatic Non-Small Cell Lung Cancer By: Rafael Santana-Davila, MD View PDF ALK, ROS-1, RET and MET By: Raja Mudad, MD, FACP View PDF ALK, ROS-1, RET and MET By: Raja Mudad, MD, FACP View Video
